Company Legal Name
Latest Valuation
Founded Year
Headquarter
Somatus operates a specialized care model for home-based management of kidney and heart disease, combining clinical teams with technology platforms to deliver comprehensive patient care. Founded in 2016 and headquartered in McLean, Virginia, the company addresses the growing need for value-based care solutions in chronic disease management, particularly targeting high-cost conditions that benefit from coordinated, home-based interventions. Somatus differentiates itself by integrating clinical expertise with digital health tools to improve patient outcomes while reducing healthcare costs. The company continues to expand its care management capabilities and provider network to serve patients with complex chronic conditions requiring ongoing medical supervision.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.
